NeuroSense Therapeutics Ltd. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
NeuroSense Therapeutics Ltd. (NRSN) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $22.50 million as of 2023-03-20, per its 20-F filed 2026-03-31.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2026-03-31
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month |
|---|---|---|---|
| 2023-03-20 | $22.50M 20-F · filed 2026-03-31 | $22.50K 6-K · filed 2024-06-17 | |
| 2022-12-31 | $119.00K 20-F · filed 2025-04-07 |